Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹7,161 Cr
up ₹28.1 Cr vs Apr 2024
- Stocks held
- 31
- unchanged
- Top 10 weight
- 59.5%
- of the portfolio in its ten largest
- Cash & debt
- 1.6%
- cash, money market and debt
- Moves this month
- 1 in · 1 out
- added to 10, trimmed 15
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In May 2024 it disclosed 31 stocks worth ₹7,161 Cr, up ₹28.1 Cr from Apr 2024. Its largest positions were Sun Pharmaceutical Industries Limited (13.4%), Lupin Limited (7.7%), Divi's Laboratories Limited (7.5%); the ten largest together made up 59.5% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 78.2% of its equity. Cash and debt stood at 1.6%. Compared with Apr 2024 the fund entered 1 new stock and exited 1.
Against 226 other Sectoral / Thematic funds
Concentration
83%
Top-10 weight is higher than 83% of peers
Breadth
16%
Holds more stocks than 16% of peers
Cash
26%
Holds more cash than 26% of peers
Holdings in May 2024
Download CSVEvery line the fund disclosed, with the change against Apr 2024. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 13.37%
- Δ weight
- down 0.44 pts
- Value
- ₹957 Cr
- Δ value
- down ₹27.7 Cr
- Status
- Trimmed
- Weight
- 7.74%
- Δ weight
- down 0.80 pts
- Value
- ₹554 Cr
- Δ value
- down ₹55.1 Cr
- Status
- Trimmed
- Weight
- 7.52%
- Δ weight
- up 2.47 pts
- Value
- ₹539 Cr
- Δ value
- up ₹178 Cr
- Status
- Added
- Weight
- 6.26%
- Δ weight
- up 0.18 pts
- Value
- ₹449 Cr
- Δ value
- up ₹14.6 Cr
- Status
- Added
- Weight
- 5.29%
- Δ weight
- down 0.12 pts
- Value
- ₹379 Cr
- Δ value
- down ₹7 Cr
- Status
- Trimmed
- Weight
- 4.45%
- Δ weight
- down 0.34 pts
- Value
- ₹319 Cr
- Δ value
- down ₹22.7 Cr
- Status
- Trimmed
- Weight
- 4.37%
- Δ weight
- up 0.29 pts
- Value
- ₹313 Cr
- Δ value
- up ₹21.9 Cr
- Status
- Added
- Weight
- 3.77%
- Δ weight
- up 0.16 pts
- Value
- ₹270 Cr
- Δ value
- up ₹12.6 Cr
- Status
- Added
- Weight
- 3.59%
- Δ weight
- up 0.49 pts
- Value
- ₹257 Cr
- Δ value
- up ₹36.1 Cr
- Status
- Added
- Weight
- 3.16%
- Δ weight
- down 0.54 pts
- Value
- ₹227 Cr
- Δ value
- down ₹37.6 Cr
- Status
- Trimmed
- Weight
- 3.15%
- Δ weight
- up 0.15 pts
- Value
- ₹226 Cr
- Δ value
- up ₹11.4 Cr
- Status
- Added
- Weight
- 3.14%
- Δ weight
- up 0.14 pts
- Value
- ₹225 Cr
- Δ value
- up ₹10.6 Cr
- Status
- Added
- Weight
- 3.12%
- Δ weight
- up 0.63 pts
- Value
- ₹224 Cr
- Δ value
- up ₹45.5 Cr
- Status
- Added
- Weight
- 3.12%
- Δ weight
- down 0.08 pts
- Value
- ₹224 Cr
- Δ value
- down ₹4.8 Cr
- Status
- Trimmed
- Weight
- 2.98%
- Δ weight
- up 0.07 pts
- Value
- ₹214 Cr
- Δ value
- up ₹5.8 Cr
- Status
- Added
- Weight
- 2.84%
- Δ weight
- up 0.09 pts
- Value
- ₹204 Cr
- Δ value
- up ₹7.1 Cr
- Status
- Added
- Weight
- 2.69%
- Δ weight
- down 0.29 pts
- Value
- ₹193 Cr
- Δ value
- down ₹20.2 Cr
- Status
- Trimmed
- Weight
- 2.49%
- Δ weight
- down 0.22 pts
- Value
- ₹179 Cr
- Δ value
- down ₹14.7 Cr
- Status
- Trimmed
- Weight
- 2.27%
- Δ weight
- up 0.04 pts
- Value
- ₹163 Cr
- Δ value
- up ₹3.2 Cr
- Status
- Added
- Weight
- 2.05%
- Δ weight
- up 0.15 pts
- Value
- ₹147 Cr
- Δ value
- up ₹11.2 Cr
- Status
- Added
- Weight
- 1.86%
- Δ weight
- down 0.69 pts
- Value
- ₹133 Cr
- Δ value
- down ₹49 Cr
- Status
- Trimmed
- Weight
- 1.86%
- Δ weight
- up 0.14 pts
- Value
- ₹133 Cr
- Δ value
- up ₹10.2 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 1.62%
- Δ weight
- down 2.22 pts
- Value
- ₹116 Cr
- Δ value
- down ₹158 Cr
- Status
- Trimmed
- Weight
- 1.57%
- Δ weight
- up 1.57 pts
- Value
- ₹113 Cr
- Δ value
- up ₹113 Cr
- Status
- New
- Weight
- 1.51%
- Δ weight
- down 0.09 pts
- Value
- ₹108 Cr
- Δ value
- down ₹5.8 Cr
- Status
- Trimmed
- Weight
- 1.06%
- Δ weight
- down 0.03 pts
- Value
- ₹75.6 Cr
- Δ value
- down ₹1.9 Cr
- Status
- Trimmed
- Weight
- 1.01%
- Δ weight
- down 0.08 pts
- Value
- ₹72.5 Cr
- Δ value
- down ₹5.5 Cr
- Status
- Trimmed
- Weight
- 0.77%
- Δ weight
- down 0.07 pts
- Value
- ₹55.1 Cr
- Δ value
- down ₹4.9 Cr
- Status
- Trimmed
- Weight
- 0.55%
- Δ weight
- up 0.07 pts
- Value
- ₹39.6 Cr
- Δ value
- up ₹5.4 Cr
- Status
- Added
- Weight
- 0.51%
- Δ weight
- down 0.07 pts
- Value
- ₹36.8 Cr
- Δ value
- down ₹5.1 Cr
- Status
- Trimmed
- Weight
- 0.20%
- Δ weight
- down <0.01 pts
- Value
- ₹14.4 Cr
- Δ value
- down ₹21 L
- Status
- Trimmed
- Weight
- 0.07%
- Δ weight
- up <0.01 pts
- Value
- ₹4.8 Cr
- Δ value
- up ₹10 L
- Status
- Added
What changed, Apr 2024 to May 2024
New New positions (1)
- Dr. Lal Path Labs Limited1.6% · ₹113 Cr
Exited Exited (1)
- Metropolis Healthcare Limitedwas 0.5% · ₹38 Cr
Added Biggest additions
- Divi's Laboratories Limitedup ₹178 Cr (+2.47% pts)
- GlaxoSmithKline Pharmaceuticals Limitedup ₹45.5 Cr (+0.63% pts)
- Vijaya Diagnostic Centre Limitedup ₹36.1 Cr (+0.49% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Apr 2024, the weight rose most in Healthcare Services (+0.8 pts), and fell most in Pharmaceuticals & Biotechnology (−0.8 pts).
- Healthcare Services17.0% → 17.9%+0.8 pts
- Pharmaceuticals & Biotechnology79.0% → 78.2%−0.8 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | May 2021 | May 2023 | Nov 2023 | Feb 2024 | Apr 2024 | May 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 79.0% | 76.3% | 76.6% | 78.9% | 79.0% | 78.2% |
| Healthcare Services | 17.5% | 18.5% | 18.2% | 17.2% | 17.0% | 17.9% |
| Retailing | — | 3.5% | 4.0% | 3.1% | 3.1% | 3.2% |
| Pharmaceuticals | 2.6% | 1.4% | 1.1% | 0.9% | 0.9% | 0.8% |
Allocation in May 2024change vs Apr 2024
- Pharmaceuticals & Biotechnology (21)78.2%▼ 0.8 pts
- Healthcare Services (8)17.9%▲ 0.8 pts
- Retailing (1)3.2%▲ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, May 2024
1.6%
▼ 2.2 pts vs Apr 2024
- Cash alone
- 1.7%
- cash and net receivables
- A year earlier
- 2.0%
- May 2023 · now ▼ 0.4 pts
- Last 12 months
- 0.5% – 3.9%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.